To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Personalis by 1,349 shares, the number of shares held decreased 93.42% compared to the previous period and now represents 0.000077% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Eli Lilly by 360 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 4.3% of the total position.
      10Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 5,250 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 1.83% of the total position.
      21Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Kymera Therapeutics, Inc. by 705 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 0.82% of the total position.
      43Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 29,555 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 1.66% of the total position.
      29Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 9,465 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 1.09% of the total position.
      71Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 3,465 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 1.91% of the total position.
      3Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 15,535 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 2.1% of the total position.
      50Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 2,405 shares, the number of shares held decreased 0.19% compared to the previous period and now represents 7.7% of the total position.
      59Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 91,815 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 2.85% of the total position.
      713Comment
      Report
       
       
       
       

      Most Discussed